Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Valeria Napolitano(Helmholtz Zentrum München), Krzysztof Pyrć(Jagiellonian University)
Cited by 61
Related Papers
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
|Clinical Microbiology Reviews|2021|219
APOBEC3-mediated restriction of RNA virus replication
|Scientific Reports|2018|129
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
|Journal of Virology|2020|102
Feline herpesvirus 1 (FHV-1) enters the cell by receptor-mediated endocytosis
|Journal of Virology|2023|52
HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV
|bioRxiv (Cold Spring Harbor Laboratory)|2020|41